Texas Medical Center
Texas Children's Specialty Care Sugar Land
15400 Southwest Freeway
Sugar Land, TX 77478
Fadel E. Ruiz, MD
Dr. Ruiz's two major interests are in the area of Cystic Fibrosis and Pediatric Pulmonary Hypertension. He has participated in several studies sponsored by the Cystic Fibrosis Therapeutic Development Network. He actively participates in multiple clinical trials related to Cystic Fibrosis. Heis also the principal investigator in several clinical trials studying the use of vasodilator therapies for the treatment of Pulmonary Hypertension in Children.
Cystic Fibrosis Lung Transplant Recipients 10 years of age or Younger: Predisposing Factors for End-stage Disease. Melicoff E, Ruiz FE, Hosek K, Mallory GB. Pediatr Pulmonol. 2022 Mar 3. doi: 10.1002/ppul.25882. Online ahead of print.PMID: 35243829.
Opportunities and challenges of pharmacotherapy for pulmonary arterial hypertension in children. Kam CW, Ruiz FE. Pediatr Pulmonol. 2021 Mar;56(3):593-613. doi: 10.1002/ppul.25101. Epub 2020 Oct 12.PMID: 33002306.
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.